Showing 3 of 3 recruiting trials for “Familial platelet disorder with associated myeloid malignancy”
Low-Dose Sirolimus to Increase Hematopoietic Function in Patients With RUNX1 Familial Platelet Disorder
Protocol Title: Safety and Feasibility of Autologous CD34+ Hematopoietic Stem Cells Mobilization and Apheresis in Participants With RUNX1 Familial Platelet Disorder
RecruitingNCT03854318 ↗
Longitudinal Studies of Patient With FPDMM
👨⚕️ Paul Liu, M.D., National Human Genome Research Institute (NHGRI)📍 1 site📅 Started Mar 2019View details ↗
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →